90325-36-3 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromopyridine-3,4-dicarboxylic acid is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to the advancement of medicine and healthcare.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Bromopyridine-3,4-dicarboxylic acid serves as a building block for the creation of new agrochemicals. Its incorporation into these compounds can enhance crop protection and yield, supporting sustainable agriculture practices.
Used in Material Science:
5-Bromopyridine-3,4-dicarboxylic acid is employed in the development of new materials, leveraging its chemical properties to engineer innovative substances with unique characteristics and applications.
Used in Organic Chemistry:
As a versatile organic compound, 5-Bromopyridine-3,4-dicarboxylic acid is used in various organic synthesis processes. Its reactivity and functional groups make it a valuable component in the preparation of complex organic molecules and biologically active compounds.
Used in Drug Discovery:
5-Bromopyridine-3,4-dicarboxylic acid plays a crucial role in drug discovery, acting as a starting material for the synthesis of potential therapeutic agents. Its presence in the development pipeline underscores its importance in the ongoing quest for new treatments and cures.
Check Digit Verification of cas no
The CAS Registry Mumber 90325-36-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,3,2 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90325-36:
(7*9)+(6*0)+(5*3)+(4*2)+(3*5)+(2*3)+(1*6)=113
113 % 10 = 3
So 90325-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrNO4/c8-4-2-9-1-3(6(10)11)5(4)7(12)13/h1-2H,(H,10,11)(H,12,13)
90325-36-3Relevant academic research and scientific papers
NOVEL ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
-
Paragraph 0376; 0379-0380, (2020/01/22)
Disclosed are a novel isoindoline derivative, a pharmaceutical composition and use thereof. The compound of formula I, or the pharmaceutically acceptable salt, solvate, polymorph, co-crystal, stereoisomer, isotopic compound, metabolite or prodrug thereof disclosed in the invention can regulate the generation and/or activity of PDE4 and/or TNF-α so as to effectively treat cancer and inflammatory diseases.
Directed lithiation of unprotected pyridinecarboxylic acids: Syntheses of halo derivatives
Lazaar, Jalal,Rebstock, Anne-Sophie,Mongin, Florence,Godard, Alain,Trécourt, Fran?ois,Marsais, Francis,Quéguiner, Guy
, p. 6723 - 6728 (2007/10/03)
Deprotonation of all isomeric lithium pyridinecarboxylates and subsequent trapping with hexachloroethane or iodine afforded straightforward access to chloro- and iodopyridinecarboxylic acids, respectively. Starting from lithium 5-bromonicotinate, the introduction of an iodine atom at C4 and further halogen migration allowed the potential of this method to be extended to the synthesis of more elaborate derivatives.
